Turin's NIB Biotec wins €5,000 Innovation Village Award for prostate test
What's the deal? NIB BiotecDealroom has a profile for this one. Try Dealroom →, a University of Turin spin-off, won the 2026 Innovation Village Award on November 16 in Naples, taking a €5,000 cash prize for a non-invasive urine test that supports prostate cancer diagnosis and monitoring. Chief executive Sergio Occhipinti presented the project, which beat 21 other finalists.
How it works: The test measures urinary biomarkers linked to the disease's presence and progression, with the aim of cutting the use of invasive procedures. NIB pairs it with an AI platform that combines results with a patient's clinical data to support risk assessment.
By the numbers: The eighth edition of the award drew 205 applications from across Italy, narrowed to 22 finalists and judged by 150 jurors from universities, companies, incubators, banks, and investors. Second place went to Laura Gallo of Lombardy for nanocellulose extracted from coffee grounds.
In their words: NIB's project holds an international patent and "aims to develop a more accurate diagnostic test than the current one," Occhipinti said (translated from Italian), one usable in hospitals and local clinics to decentralise screening.
What's the endgame? NIB says its ZenPSA-pro measures urinary PSA and zinc to help clinicians judge whether further investigation, such as an MRI or biopsy, is warranted. The product remains limited to clinical investigations and is not commercially available; the company has described further validation and a possible European launch in 2027.
Why now? The prize follows research using the test winning the European Association of Urology's 2026 Helmut Haas Award, lending academic weight ahead of any commercial push.
The signal: The award is an ecosystem prize, not proof of commercial readiness — it may help NIB attract partners, but it does not by itself establish clinical utility or market adoption. The gap between clinical interest and completed validation remains the test to watch.
Read more: canaleuno.it
Image credit: "200206-N-VI515-1020" by NavyMedicine, public domain (Public Domain Mark 1.0)